Fig. 3From: 18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysisRelation between event-free survival (EFS) and baseline tumor metabolically active tumor volume (MATV) (a), total lesion glycolysis (TLG) (b), homogeneity (H) (c), and entropy (E) (d) in 143 patients with ER+/HER2- breast cancerBack to article page